Patellar resurfacing versus nonresurfacing in total knee arthroplasty for osteoarthritis: experience at a tertiary care institution in Pakistan
Akil Fazal1, Riaz H Lakdawala2
1Clinical Fellow, NYU Hospital for Joint Disease, New York, US; 2Associate Professor and Chief, Section of Orthopedics, Department of Surgery, The Aga Khan University Hospital, Karachi, Pakistan
Objective: To determine the effect of patellar resurfacing in patients offered total knee arthroplasty for osteoarthritis.
Design: Randomized control study.
Place and duration of study: The Aga Khan University Hospital, Karachi, Pakistan from January 3, 2005 to January 9, 2010.
Patients and methods: Patients undergoing primary total knee arthroplasty for osteoarthritis were assigned to either the patellar resurfacing or nonresurfacing arm using systematic sampling. This consisted of patients undergoing unilateral and bilateral knee arthroplasty. Preoperatively, Knee Society Knee and Function Scores were calculated. After a minimum of 3 years postoperatively Knee Society Knee and Function Scores as well as the Clinical Anterior Knee Pain Rating were calculated and analysis done to check for differences.
Results: Seventy-five patients were recruited in each arm; 135 patients had bilateral and 15 had unilateral knee arthroplasty. The mean preoperative knee score was 40.4 for the resurfacing group and 40.60 for the nonresurfacing group (P = 0.45). This improved postoperatively to 93.67 and 94.23 respectively, with no difference between the two groups (P = 0.67). The mean preoperative function score was 45.50 for resurfaced patellae and 45.83 for nonresurfaced. This improved to 89.67 and 90.50, respectively, again with no difference (P = 0.51). Postoperative Clinical Anterior Knee Pain Rating was a mean of 0.1 for resurfaced and 0.13 for nonresurfaced patellas, with no difference on analysis (P = 0.06). However, patients who had bilateral knee arthroplasty had a slightly higher Clinical Anterior Knee Pain Rating than those who had single knee surgery (P = 0.046) irrespective of whether the patellar was resurfaced or not.
Conclusion: In patients undergoing primary Total Knee Arthroplasty for osteoarthritis, there is no added advantage of performing resurfacing of the patellar at 3 years of follow-up.
Keywords: patellar, patellar ligament, patellofemoral pain syndrome, arthroplasty subchondral, arthroplasy replacement knee, osteoarthritis knee, Pakistan
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Other articles by this author:
Fourth-generation spinal instrumentation: experience with adolescent idiopathic scoliosis at a tertiary care hospital in Pakistan
Fazal A, Lakdawala RH
Published Date: 22 February 2012
Fazal A, Rashid H, Cheema T
Published Date: 24 January 2012
Readers of this article also read:
Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy
Tao KY, Li XX, Xu WZ, Wang Y, Zhu SM, Xie HX, Luo WH, Xu YJ, Xu XL
Published Date: 14 January 2015
Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women: a randomized controlled trial [Corrigendum]
Lai CL, Tseng SY, Chen CN, Liao WC, Wang CH, Lee MC, Hsu PS
Published Date: 18 June 2014
The combination of corneal collagen crosslinking with riboflavin and ultraviolet-a irridation and excimer laser surgery.
Ralla B, Holtmann C, Geerling G
Published Date: 26 March 2013
Patient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy
Auger GA, Raynor M, Longstaff S
Published Date: 11 December 2012
Development of a reduction-sensitive diselenide-conjugated oligoethylenimine nanoparticulate system as a gene carrier
Cheng G, He Y, Xie L, Nie Y, He B, Zhang Z, Gu Z
Published Date: 31 July 2012
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery
Turpie AG, Schmidt AC, Kreutz R, Lassen MR, Jamal W, Mantovani L, Haas S
Published Date: 1 June 2012
Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial disease
Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J
Published Date: 17 April 2012
Nonselective ß-blocker propranolol for orbital and periorbital hemangiomas in infants: a new first-line of treatment?
El-Essawy R, Galal R, Abdelbaki S
Published Date: 18 November 2011
Sudenga SL, Royse KE, Shrestha S
Published Date: 15 September 2011
Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study
Laura J Gray, Jennifer R Tringham, Melanie J Davies, et al
Published Date: 20 September 2010